This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
SeaSpine Holdings (SPNE) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
SeaSpine (SPNE) delivered earnings and revenue surprises of -40% and 0.34%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Recent Price Trend in Sensus Healthcare, Inc. (SRTS) is Your Friend, Here's Why
by Zacks Equity Research
Sensus Healthcare, Inc. (SRTS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Edwards Lifesciences (EW) Lags Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Edwards Lifesciences (EW) delivered earnings and revenue surprises of -1.61% and 1.32%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights TransMedics, PROCEPT BioRobotics and Sensus Healthcare
by Zacks Equity Research
TransMedics, PROCEPT BioRobotics and Sensus Healthcare are part of the Zacks top Analyst Blog Highlights.
3 Resilient Medical Stocks to Watch as Rate Hikes Continue
by Indrajit Bandyopadhyay
Here we discuss three Medical-Instruments stocks - TMDX, PRCT & SRTS - that continued to grow in the first nine months of 2022 even though three Fed rate hikes dragged broader indices down.
EDAP TMS S.A. (EDAP) Moves 7.3% Higher: Will This Strength Last?
by Zacks Equity Research
EDAP TMS S.A. (EDAP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Zacks.com featured highlights include Sensus Healthcare, Super Micro Computer, Universal Logistics Holdings, Arcosa and Celsius Holdings
by Zacks Equity Research
Sensus Healthcare, Super Micro Computer, Universal Logistics Holdings, Arcosa and Celsius Holdings are part of Zacks screen of the week article.
5 Stocks With Recent Price Strength to Enrich Your Portfolio
by Nalak Das
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are SRTS, SMCI, ULH, ACA and CELH.
Sensus Healthcare, Inc. (SRTS) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Sensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of 16.67% and 17.57%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Semler Scientific Inc. (SMLR) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Semler Scientific Inc. (SMLR) delivered earnings and revenue surprises of 27.50% and 0.05%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks Value Investor Highlights: Merck, Maravai LifeSciences, Sensus Healthcare, PetIQ and AbbVie
by Zacks Equity Research
Merck, Maravai LifeSciences, Sensus Healthcare, PetIQ and AbbVie have been highlighted in this Value Investor article.
5 Cheap Healthcare Stocks in 2022
by Tracey Ryniec
Looking for value stocks? Healthcare has been ignored over the last year.
Sensus Healthcare, Inc. (SRTS) Is a Great Choice for "Trend" Investors, Here's Why
by Zacks Equity Research
Sensus Healthcare, Inc. (SRTS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Sensus Healthcare, Inc. (SRTS) Soars 8.7%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Sensus Healthcare, Inc. (SRTS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Factors that Make Molina Healthcare (MOH) an Attractive Bet Now
by Zacks Equity Research
Molina Healthcare (MOH) continues to ride on sustained top-line growth, well-performing Medicare and Medicaid businesses, and a strong cash position.
Is the Options Market Predicting a Spike in Sensus Healthcare (SRTS) Stock?
by Zacks Equity Research
Investors need to pay close attention to Sensus Healthcare (SRTS) stock based on the movements in the options market lately.
HCA Healthcare (HCA) Boosts Cancer Portfolio With McKesson JV
by Zacks Equity Research
HCA Healthcare (HCA) inks a joint venture with McKesson to strengthen the cancer offerings suite of both partners. The move will offer HCA the chance to capitalize on the growing cancer therapeutics market.
Anthem (ANTM) Unveils Two Brands to Boost Whole Person Health
by Zacks Equity Research
Anthem (ANTM) launches Carelon and Wellpoint brands to streamline its products and services portfolio as well as bring about enhanced health plans for clients and consumers.
Has Altimmune (ALT) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Altimmune, Inc. (ALT) and Sensus Healthcare, Inc. (SRTS) have performed compared to their sector so far this year.
Wall Street Analysts Believe Sensus Healthcare, Inc. (SRTS) Could Rally 55%: Here's is How to Trade
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 54.6% in Sensus Healthcare, Inc. (SRTS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Why Sensus Healthcare, Inc. (SRTS) Might be Well Poised for a Surge
by Zacks Equity Research
Sensus Healthcare, Inc. (SRTS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Wall Street Analysts Think Sensus Healthcare, Inc. (SRTS) Could Surge 53%: Read This Before Placing a Bet
by Zacks Equity Research
The consensus price target hints at a 52.9% upside potential for Sensus Healthcare, Inc. (SRTS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Is Assertio (ASRT) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how Assertio (ASRT) and Sensus Healthcare, Inc. (SRTS) have performed compared to their sector so far this year.
Sensus Healthcare, Inc. (SRTS) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Sensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of 233.33% and 65.78%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Is Assertio (ASRT) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how Assertio (ASRT) and Sensus Healthcare, Inc. (SRTS) have performed compared to their sector so far this year.